Drug Abuse Warning Network (DAWN): ED Visits Involving Alcohol Short Report presents the following data from January 2021-September 2023 (1) national estimates and characteristics of alcohol-related ED visits (2) demographics of alcohol-related ED visits (3) percent of ED visits related to alcohol and at least one other substance.
Search Results
Explore gender differences among young adults for: any mental illness, serious mental illness, major depressive episodes, mental health treatment, and suicidal behavior. Estimates were based on data from the 2021 National Survey on Drug Use and Health (NSDUH).
This report presents the total number of admissions to and discharges from substance use treatment services in 2021 by demographics, National Outcome Measures (NOMs), morbidity status, and the top six primary substances by geographic distribution. The NOMs presented in this report include stability in housing, employment status, criminal justice involvement...
This report describes the total number of clients receiving mental health treatment services in 2021 by demographics, National Outcome Measures (NOMs) and the top five mental health diagnoses for children (ages 0 - 17) and adults (18 and older) by geographical distribution. The NOMs presented in this report include stability...
Drug Abuse Warning Network (DAWN): Drug-Related ED Visits Involving Suicide Attempts Short Report presents (1) national estimates and characteristics of drug-related ED visits involving suicide attempts and (2) the top substance involved in suicide attempts.
Find key substance use and mental health indicators by sexual identity -- gay/lesbian, bisexual, and straight-- and gender among adults aged 18 or older in the United States. Estimates were based on combined data from the 2021 and 2022 National Surveys on Drug Use and Health (NSDUH) and were age-adjusted...
Use these slides to explore substance use and mental health measures for particular populations in the United States. The slides are based on the 2021 National Survey on Drug Use and Health (NSDUH), which is administered to civilians 12 and older not living in institutions. Within each slide deck, selected...
Drug Abuse Warning Network (DAWN) Non-Fatal Overdoses Short Report presents: (1) national estimates and characteristics of non-fatal overdose ED visits, (2) the identification of top substances involved in these visits and (3) the prevalence of polysubstance related non-fatal overdose ED visits. Additional report resources are also available in the Non-Fatal...
This report presents results from the 2021 National Substance Use and Mental Health Services Survey (N-SUMHSS), an annual census of facilities providing substance use and mental health treatment. Conducted by the Substance Abuse and Mental Health Services Administration (SAMHSA), the N-SUMHSS is designed to collect data on the location, characteristics...
Read key findings from the 2021 National Survey on Drug Use and Health (NSDUH) on substance use, mental health, and treatment. Metrics in the report cover the civilian, noninstitutionalized US population ages 12 and older. Estimates are presented by age group and by race/ethnicity for selected measures. Unlike other NSDUH...
An analysis of final 2021 DAWN data presents: (1) nationally representative weighted estimates, including percent and unadjusted rates per 100,000, for all drug-related ED visits, (2) nationally representative weighted estimates for the top five drugs in drug-related ED visits, (3) the assessment of monthly trends and drugs involved in polysubstance...
These are the 2021 Uniform Reporting System (URS) Output Tables. The URS state reporting system is collected annually to support the Community Mental Health Services Block Grant program. State Mental Health Authorities report on National Outcome Measures (NOMS), evidence-based practices, and utilization measures providing an overview of state mental health delivery systems.
Preliminary Findings from Drug-Related Emergency Department Visits, 2021. An analysis of 2021 preliminary data presents (1) nationally representative weighted estimates for the top five drugs in drug-related ED visits, (2) the assessment of monthly trends and drugs involved in polysubstance ED visits in a subset of sentinel hospitals, and (3)...